Abu Dhabi rewrote its home-DME policy for the first time since 2017, and the maintenance clock is now a licensing risk.
Policy/DME/HPS/V2/2026 rewrites how home DME is coded, reimbursed, and maintained in Abu Dhabi — with a 10-day access target, 24/48/6-hour service SLAs, and DoH power to suspend an accreditation or a supplier contract.
What a board member needs before the next meeting on this.
- DME reimbursement is on a new rulebook after nine years. Policy/DME/HPS/V2/2026 replaces V1.0 of November 2017 and covers every DoH-licensed provider, every DoH-authorised payer, and every insurance product for DME used in a patient's home.
- Service delays are now measured in hours, not visits. Initial response within 24 hours, corrective maintenance within 48 hours, temporary replacement within 6 hours for life-support DME, 24 hours for assistive DME, 48 hours for other DME.
- The access KPI is a hard number. Over 95% of eligible patients must receive prescribed DME within 10 calendar days. That is the yardstick a payer will use in disputes and a buyer should use in diligence.
- Non-compliance can suspend the accreditation, not just the invoice. The DoH may formally review supplier and provider conduct and impose penalties up to suspension of accreditation or supplier contracts. In diligence this is a going-concern line, not a fine line.
Abu Dhabi's home-DME market has been running on a 2017 policy for nearly a decade. In May 2026 the Department of Health published Policy/DME/HPS/V2/2026, effective April 2026, replacing V1.0 of November 2017. It applies to every DoH-licensed healthcare provider, every DoH-authorised payer, and every health-insurance product covering durable medical equipment used in a patient's home. That is a wide net: distributors, home-health providers, hospital-affiliated pharmacies dispensing DME, third-party administrators, and payers all sit under the same document.
The reimbursement rails have moved onto HCPCS and Shafafiya
Providers and payers must use HCPCS codes through the DoH Shafafiya platform and maintain a dynamic DME list. Standard Provider Contracts govern pricing, reimbursement, purchase, rental, supplies and replacements. For a home-DME target whose revenue still runs on ad-hoc codes or on legacy contracts, that is a repapering exercise, not a formatting one, and a buyer should assume the run-rate needs to be re-underwritten against the new coding and claims discipline.
Service SLAs are now the compliance metric
V2 turns maintenance into a timed obligation. Initial response and communication within 24 hours of a maintenance request. Corrective maintenance completed within 48 hours. For life-support DME — ventilators, oxygen concentrators — a temporary replacement is mandatory if repair or replacement will exceed six hours. For assistive DME — wheelchairs, walkers — the threshold is 24 hours. For other DME the threshold is 48 hours. Preventive maintenance runs at least annually per manufacturer guidance and ISO 13485:2016, and every device must carry a PPM tag showing the last completed maintenance, the next scheduled date, and the authorised maintenance provider. For a diligence read, these are the numbers to reconcile against the target's own SLA log; a large volume of near-miss breaches is a red flag on its own.
The access target is a number, not an aspiration
V2 sets the key success factor at >95% of eligible patients receiving prescribed DME within 10 calendar days. The compliance KPI is 100% of DME meeting FDA, EMA or MOHAP standards. The safety KPI is fewer than 1% adverse events reported annually through DoH surveillance. The cost-effectiveness KPI is >80% of reimbursements using the least costly clinically appropriate option. These are the yardsticks a payer will cite in a dispute and a fund manager should cite in an investment memo. A target running well below any of them is carrying an unbooked repricing risk.
Escalation and enforcement have real teeth
Where a supplier fails to hit a temporary-replacement or maintenance deadline, the healthcare provider must escalate to the supplier's senior management within two hours of the deadline and file a report to the payer via the Tamm platform within four hours. Providers must conduct quarterly maintenance audits and, where deficiencies surface, produce a corrective action plan within 14 days. The teeth are in section 8.1: the DoH may impose sanctions for any breach in accordance with the disciplinary regulation of the healthcare sector, and section 3.4.5.6 permits penalties up to suspension of provider accreditation or supplier contracts. That moves DME compliance from a cost line into a covenant on the underlying licence.
What sits outside the new policy
The document is explicit about scope. It does not cover inpatient hospital DME, disposable supplies such as catheters and bandages, devices purchased outside Abu Dhabi without payer pre-authorisation, or non-medical equipment such as air purifiers. For a target with a mixed inpatient-outpatient DME book, the V2 obligations attach only to the home-use portion; a buyer's diligence needs to separate the two revenue streams and read each on its own rulebook.
Four questions before a home-DME deal in Abu Dhabi
- Does the target's SLA record clear the 24/48-hour and 6/24/48-hour temporary-replacement thresholds?
- Are HCPCS-coded claims running clean through Shafafiya, or are there open coding disputes?
- Do maintenance and quality logs meet ISO 13485:2016, and does every device carry the required PPM tag?
- Where are the V1-era Standard Provider Contracts that still need to be repapered against V2?
The near-term work for anyone holding or chasing an Abu Dhabi home-DME asset is concrete: pull the last twelve months of maintenance logs against the 24/48-hour and 6/24/48-hour thresholds, verify the HCPCS-to-Shafafiya flow is clean, and check whether any Standard Provider Contract still runs on V1 terms. That structuring and diligence work is where our transactions and capital practice begins.